Tissue Regenix, a regenerative medtech firm, signs deal with US partner to provide grafts for chronic wound suffers in America.
Leeds spin-out Tissue Regenix has signed a processing partnership with US tissue bank Community Tissue Service, marking a major step forward for the commercialisation strategy of the Yorkshire-based medtech firm.
Founded in 2006, Tissue Regenix is commercialising a biological scaffolding technology which enhances healing in chronic wound conditions. 87% of patients treated with the firm’s medtech product, dCELL, have seen a reduction in the size of their wounds, whereas 60% had their wounds healed completely.
Community Tissue Services currently distributes…
